ChromoCure, Inc.
KKUR News Today: Stay Updated with the Latest ChromoCure, Inc. News in Real Time
Find KKUR news now at Meyka AI. Stay informed with the latest ChromoCure, Inc. stocks updates, including price news, market analysis, and expert insights.
Jefferies Maintains Buy on PSTL, Raises Postal Realty Trust PT to $24 Feb 25 2026
Jefferies maintains Buy and raises PT to $24. PSTL analyst rating update and investor implications Feb 25, 2026
Volume spike: TICO.CN Talent Infinity (CNQ) at C$0.12 Feb 2026: watch liquidity
TICO.CN stock jumps to C$0.12 on volume spike Feb 2026; Meyka AI forecast shows ~100.26% upside potential
BMO Maintains Outperform on LFST LifeStance Health Group Feb 2026, PT $10
LFST analyst rating update: BMO maintains Outperform and raises price target to $10 from $8 on Feb 25, 2026
Needham Maintains Buy on Ionis Pharmaceuticals (IONS) Feb 25, 2026
IONS analyst rating update: Needham maintains Buy and raises PT to $103; RBC reiterates Outperform on Feb 25, 2026
Volume to C$0.25: SMC.TO Sulliden Mining (TSX) 25 Feb 2026, forecast flags risk
SMC.TO stock rose to C$0.25 on heavy volume on 25 Feb 2026. We review drivers, metrics, Meyka forecast and price targets.
Citigroup Maintains Neutral on Atlanta Braves Holdings (BATRK) Feb 25, 2026
Citigroup maintained Neutral on Atlanta Braves. Read our take on the BATRK analyst rating and the $49 price target
Evercore ISI Maintained Outperform for Penumbra, Inc. (PEN) Feb 25, 2026
Evercore ISI maintained Outperform and raised PT to $360 on Feb 25, 2026 for PEN analyst rating insight
ALC.SW Alcon Inc. (SIX) ends CHF64.26 25 Feb 2026: heavy volume, earnings focus
ALC.SW stock closed at CHF64.26 on 25 Feb 2026 with volume 1,407,710; trading shows earnings focus
F3A.DE falls 14.78% to €177.90 on XETRA 25 Feb 2026: analyse near-term catalysts
F3A.DE stock fell 14.78% to €177.90 on XETRA 25 Feb 2026; we analyse drivers, valuation and Meyka AI forecast.